Protective effects of the ethanolic extract of melia toosendan fruit against colon cancer

Indian Journal of Biochemistry and Biophysics

Volumn 49, Issue 3, 2012, Pages 173-181

  Tang, Xue Lian ^a,b   Yang, Xin Ying ^a,c   Kim, Youn Chul ^a   Kim, Sung Yeon ^a   Kang, Baek Dong ^a   Choi, Du Young ^a   Kimg, Ok jin ^a   Park, Won Cheol ^a   Park, Hyun ^a  

^a Wonkwang University   (South Korea)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; Colon cancer; Melia toosendan fruit

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT;

ADENOCARCINOMA; ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMISTRY; COLON TUMOR; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; FEMALE; FRUIT; HUMAN; ISOLATION AND PURIFICATION; MELIA; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYTOCHROMES C; FEMALE; FRUIT; HUMANS; MELIA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MITOCHONDRIA; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MELIA TOOSENDAN; MURINAE;

EID: 84924287337     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gennarelli M, Jandorf L, Cromwell C, Valdimarsdottir H, Redd W & Itzkowitz S (2005) Mt Sinai J Med 72, 36-44
2. Siegel R, Naishadham D & Jemal A (2012) CA Cancer J Clin 62, 10-29
3. Cragg G M & Newman D J (2005) J Ethnopharmacol 100, 72-79
4. Johnson I S, Armstrong J G & Gorman M (1963) Cancer Res 23, 1390-1397
5. Wani M C, Taylor H L, Wall M E, Coggon P & McPhail A T (1971) J Am Chem Soc 93, 2325-2327
6. Kepler J A, Wani M C, McNaull J N, Wall M E & Levine S G (1969) J Org Chem 34, 3853-3858
7. Lu Z Q (1997) Inner Mongolia J Tradit Chin Med 1, 45-46
8. Wei C H & Lv J H (1997) J Pract Med Tech 7, 561-562
9. Chinese Pharmacopoeia Committee (2005) Chinese Pharmacopoeia 1, 29
10. Shi Y L & Li M F (2007) Prog Neurobiol 82, 1-10
11. Zhang Q, Shi Y, Liu X T, Liang J Y, Ip N Y & Min Z D (2007) Planta Med 73, 1298-1303
12. He Y, Wang J, Liu X, Zhang L, Yi G, Li C, He X, Wang P & Jiang H (2010) Planta Med 13, 1447-1453
13. Zhang B, Wang Z F, Tang M Z & Shi Y L (2005) Invest New Drugs 23, 547-553
14. Kim H M, Oh G T, Han S B, Hong D H, Hwang B Y, Kim Y H & Lee J J (1994) Arch Pharm Res 17, 100-103
15. Ritz V & Steinfelder H J (2000) Anal Biochem 287, 183-185
16. Steinfelder H J, Quentin I & Ritz V (2000) J Pharmacol Toxicol Methods 43, 79-84
17. Druzhyna N M, Hollensworth S B, Kelley M R, Wilson G L & Ledoux S P (2003) Glia 42, 370-378
18. Chikkanna-Gowda C P, McNally S, Sheahan B J, Fleeton M N & Atkins G J (2006) Oncol Rep 16, 713-719
19. Reagan-Shaw S, Nihal M & Ahmad N (2008) FASEB J 22, 659-661
20. Kurooka M & Kaneda Y (2007) Cancer Res 67, 227-236
21. Wolpin B M & Mayer R J (2008) Gastroenterology 134, 1296-1310
22. Smith M & Boon H S (1999) Patient Educ Couns 38, 109-120
23. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H & Haga N (2003) Cancer Sci 94, 15-21
24. Borner C (2003) Mol Immunol 39, 615-647
25. Zimmermann K C, Bonzon C & Green D R (2001) Pharmacol Ther 92, 57-70
26. Penninger J M & Kroemer G (2003) Nat Cell Biol 5, 97-99
27. Nicholson D W & Thornberry N A (1997) Trends Biochem Sci 22, 299-306
28. Britten C D, Hilsenbeck S G, Eckhardt S G, Marty J, Mangold G, MacDonald J R, Rowinsky E K, Von Hoff D D & Weitman S (1999) Cancer Res 59, 1049-1053